Home Investors News Press Releases

If you would like to be alerted when a press release is added to this site, please register with the Alerting Service.

Select a month	AllJanuary February March April May June July August September October November December
Select a year	All2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Search for:

06/09/2009	Cyclacel to present at Annual Needham Biotechnology and Medical Technology Conference
06/08/2009	Sapacitabine has anti-cancer activity in combination with targeted agents & other nucleoside analogs
05/29/2009	Cyclacel Reports initial phase 2 seliciclib data in patients with nasopharyngeal carcinoma at 2009 Asco Annual Meeting
05/29/2009	Cyclacel Reports phase 2 sapacitabine data in patients with acute myeloid leukemia and myelodysplastic syndromes at 2009 Asco Annual Meeting
05/14/2009	Cyclacel Pharmaceuticals reports financial results for first quarter 2009
05/07/2009	Cyclacel Pharmaceuticals to announce release of First Quarter 2009 Financial Results and upcoming corporate events
04/22/2009	Cyclacel & Dartmouth researchers report novel mechanism of action for seliciclib at AACR
04/16/2009	Cyclacel Pharmaceuticals announces multiple presentations at American Association of Cancer Research Annual Meeting
04/08/2009	Cyclacel Pharmaceuticals announces suspension of quarterly dividend on 6% Convertible Exchangeable Preferred Stock
03/31/2009	Cyclacel Pharmaceuticals announces Financial Results for Fourth Quarter and year ended December 31, 2008
1  2    >>

  Go to top      Print page